Katrina Allen, MD
Obstetrics & Gynecology · Fort Worth, TXNPI 1336123744
Payments from drug & device makers
Across 191 payments — averaging $29.49 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Mimedx Group, Inc.$2K
- AbbVie$756
- Pfizer$429
- Astellas Pharma US Inc$327
- Medical Device Business Services, Inc.$325
- Exeltis, USA Inc.$247
- plus $2K from 30 others
What the payments were for
- Consulting fees$1,80032%
- Food & beverage$3,49662%
- Education$3366%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Mimedx Group, Inc. | 6 | $1,841 |
| AbbVie(2 entities) | 42 | $756 |
| Pfizer | 28 | $429 |
| Astellas Pharma US Inc | 20 | $327 |
| Medical Device Business Services, Inc. | 1 | $325 |
| Exeltis, USA Inc. | 14 | $247 |
| Mayne Pharma Commercial LLC | 8 | $199 |
| Hologic Sales And Service, LLC | 6 | $172 |
| Sumitomo Pharma America, Inc. | 8 | $160 |
| Organon | 8 | $137 |
| Millicent US Inc | 5 | $110 |
| Shield Therapeutics Inc | 1 | $95 |
| Merck | 5 | $75 |
| Axonics, Inc. | 3 | $64 |
| Coopersurgical, Inc. | 3 | $57 |
| Biogen | 3 | $52 |
| Evofem Biosciences, Inc. | 2 | $43 |
| Myovant Sciences Inc. | 2 | $41 |
| Medtronic | 2 | $40 |
| Avion Pharmaceuticals | 3 | $40 |
| Baxter Healthcare | 1 | $39 |
| Aspira Women's Health Inc | 2 | $37 |
| Agile Therapeutics, Inc. | 2 | $35 |
| Therapeuticsmd, Inc. | 2 | $34 |
| Innovation Technologies Inc | 1 | $33 |
| Duchesnay USA Incorporated | 2 | $32 |
| Minerva Surgical, Inc | 2 | $31 |
| Organogenesis Inc. | 1 | $30 |
| Davol Inc. | 1 | $30 |
| Daiichi Sankyo Inc. | 1 | $25 |
| Bayer | 1 | $23 |
| Conmed Corporation | 1 | $17 |
| Bausch Health US, LLC | 1 | $16 |
| Meditrina | 1 | $13 |
| Johnson & Johnson | 1 | $13 |
| AMAG Pharmaceuticals, Inc. | 1 | $11 |
How this compares
$5,632 in reported general payments places this provider in the 85th percentile of 3,099 obstetrics & gynecology providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Estradiol | 18 | $451 |
Paid to pharmacies, not to this prescriber.
Other obstetrics & gynecology in Fort Worth
- Monica LopezFort Worth$8.1M
- Cynthia RobbinsFort Worth$7.8M
- Delbert JohnsFort Worth$286K
- Amir JazaeriHouston$19.5M
- Shannon WestinHouston$17.3M
- John Paul RobertsPlano$4.9M
- Stephen StamatisWeatherford$4.5M
- Parke HedgesSan Antonio$4.2M
- Mary MartinBeaumont$2.8M
- Mark JacobsHouston$2.8M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.